Antigen presentation by the CD4 positive monocyte subset.
Although CD4 antigen is expressed on monocytes (MO), its functional role is uncharacterized. In this study, isolated human MO were separated into CD4+ and CD4- MO subsets and assessed for presentation of tetanus toxoid. The CD4- MO subset had decreased antigen presenting cell (APC) capacity as well as increased PGE2 production when compared to the CD4+ MO subset. Addition of a cyclo-oxygenase inhibitor (Indomethacin) did not restore the CD4- MO subset's APC capacity to that of the similarly treated CD4+ MO subset, eliminating differential PGE2 production as the primary cause of differential APC capacity. Production of monokines such as IL-1 and plasminogen activator, which affect APC capacity, was similar in the CD4 MO subsets. However, tumor necrosis factor (TNF) production (IFN gamma plus MDP-induced) of the CD4+ MO subset was slightly greater than that of the CD4- MO. CD4- MO's lower APC capacity is not totally explained by their differential IL-1, TNF, or PGE2 production.
Szabo
G
G
Department of Surgery, University of Massachusetts Medical Center, Worcester 01655.
Miller
C L
CL
Kodys
K
K
D000328:Adult; D000938:Antigen-Presenting Cells / Q000276:immunology* / Q000378:metabolism; D015704:CD4 Antigens / Q000032:analysis*; D002469:Cell Separation / Q000379:methods; D015232:Dinoprostone / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism / Q000494:pharmacology; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology* / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology; D013745:Tetanus Toxoid / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism / Q000494:pharmacology
D015704:CD4 Antigens; D007375:Interleukin-1; D013745:Tetanus Toxoid; D014409:Tumor Necrosis Factor-alpha; D010960:Plasminogen Activators; D015232:Dinoprostone